Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Adma Biologics (ADMA) Other financing activities (2016 - 2023)

Historic Other financing activities for Adma Biologics (ADMA) over the last 8 years, with Q4 2023 value amounting to $2.4 million.

  • Adma Biologics' Other financing activities rose 326517777.78% to $2.4 million in Q4 2023 from the same period last year, while for Dec 2024 it was $2.4 million, marking a year-over-year change of 0.0%. This contributed to the annual value of $2.4 million for FY2023, which is 1552.28% down from last year.
  • According to the latest figures from Q4 2023, Adma Biologics' Other financing activities is $2.4 million, which was up 326517777.78% from $72.0 recorded in Q4 2022.
  • Adma Biologics' Other financing activities' 5-year high stood at $2.4 million during Q1 2022, with a 5-year trough of $72.0 in Q4 2022.
  • For the 3-year period, Adma Biologics' Other financing activities averaged around $1.1 million, with its median value being $980162.0 (2019).
  • Data for Adma Biologics' Other financing activities shows a peak YoY increase of 326517777.78% (in 2023) and a maximum YoY decrease of 326517777.78% (in 2023) over the last 5 years.
  • Quarter analysis of 3 years shows Adma Biologics' Other financing activities stood at $123899.0 in 2019, then tumbled by 99.94% to $72.0 in 2022, then surged by 3265177.78% to $2.4 million in 2023.
  • Its last three reported values are $2.4 million in Q4 2023, $72.0 for Q4 2022, and $404562.0 during Q3 2022.